Ultra fast-acting insulin lispro (Perosphere)

N/A

Report date: 2022/11/20 16:16:14

Base Information

Drug NameUltra fast-acting insulin lispro (Perosphere)
Drug Alias Name超速效胰岛素Lispro-PerospherePER-511
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionPhosphokinases stimulants
TargetsPhosphokinases
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPerosphere Inc
China Registration ClassN/A

Develop Information

Active CompaniesPerosphere Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A